
FDA clears Sarclisa Escena on-body injector for multiple myeloma, delivering subcutaneous doses in minutes to save patient and nurse time.

FDA clears Sarclisa Escena on-body injector for multiple myeloma, delivering subcutaneous doses in minutes to save patient and nurse time.

This article was sponsored by Bristol Myers Squibb 1992-US-2600462 09/26

Learn how PADCEV plus pembrolizumab reshapes first-line advanced urothelial cancer care—and how nurses spot and manage serious toxicities early.






An oncology research nurse balances patient care with rigorous data collection, emphasizing communication and collaboration to advance cancer research.
